Nephros Stock Investor Sentiment

NEPH Stock  USD 1.63  0.01  0.62%   
Under 52% of Nephros' investor base is interested to short. The analysis of overall sentiment of trading Nephros stock suggests that many investors are impartial at this time. Nephros' investing sentiment shows overall attitude of investors towards Nephros.
  
a minute ago at finance.yahoo.com         
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2024 Financial Results
Yahoo News
a day ago at www.macroaxis.com         
Acquisition by Gwydir Tom of 27613 shares of Nephros subject to Rule 16b-3
Macroaxis News
few days ago at news.google.com         
Nephros, Inc. Reports First Profitable Year - TipRanks
Google News at Macroaxis
few days ago at news.google.com         
Earnings call transcript Nephros Q4 2024 beats EPS forecast, stock surges - Investing.com Australia
Google News at Macroaxis
six days ago at simplywall.st         
Nephros Full Year 2024 Earnings Beats Expectations
Simply Wall St News at Macroaxis
over a week ago at finance.yahoo.com         
Nephros Announces Fourth Quarter and Fiscal Year 2024 Financial Results
Yahoo News
over a week ago at gurufocus.com         
Nephros Inc Q4 Earnings EPS of 0. ...
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Earnings To Watch Nephros Inc Reports Q4 2024 Result
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Earnings To Watch Nephros Inc Reports Q4 2024 Result
Yahoo News
over a week ago at news.google.com         
Nephros Amends CFO Employment Terms for Strategic Growth - TipRanks
Google News at Macroaxis
over a week ago at news.google.com         
Nephros Inc expected to post a loss of 1 cent a share - Earnings Preview - TradingView
Google News at Macroaxis
over two weeks ago at news.google.com         
Nephros Projected to Post Earnings on Thursday - Defense World
Google News at Macroaxis
over two weeks ago at news.google.com         
Nephros and Sintx Technologies Head to Head Analysis - Defense World
Google News at Macroaxis
over three weeks ago at thelincolnianonline.com         
Contrasting Nephros and Sintx Technologies
news
over three weeks ago at www.macroaxis.com         
Acquisition by Andrew Astor of 1000 shares of Nephros at 6.96 subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Nephros that are available to investors today. That information is available publicly through Nephros media outlets and privately through word of mouth or via Nephros internal channels. However, regardless of the origin, that massive amount of Nephros data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Nephros news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Nephros relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Nephros' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Nephros alpha.

Nephros Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Nephros Stock analysis

When running Nephros' price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets